{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:33:43Z","timestamp":1772724823061,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xphs.2026.104159","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T23:28:00Z","timestamp":1768087680000},"page":"104159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stability of therapeutic monoclonal antibodies during infusion with elastomeric pumps intended for home-based therapy"],"prefix":"10.1016","volume":"115","author":[{"given":"Elham","family":"Taherian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4929-2388","authenticated-orcid":false,"given":"Mirjam","family":"Crul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3370-6491","authenticated-orcid":false,"given":"Reza","family":"Nejadnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.xphs.2026.104159_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28186438","article-title":"Therapeutic antibodies in medicine","volume":"28","author":"Sharma","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.xphs.2026.104159_bib0002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2014.06.020","article-title":"Targeted biopharmaceuticals for cancer treatment","volume":"352","author":"Zhou","year":"2014","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.xphs.2026.104159_bib0003","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40259-018-0295-0","article-title":"Subcutaneous Administration of biotherapeutics: an overview of current challenges and opportunities","volume":"32","author":"Bittner","year":"2018","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.xphs.2026.104159_bib0004","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.21873\/anticanres.14062","article-title":"AJM VDE, Crul M. Systematic review on infusion reactions to and infusion rate of monoclonal antibodies used in cancer treatment","volume":"40","author":"Rombouts","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.xphs.2026.104159_bib0005","unstructured":"Laughlin Amy I, Begley M, Delaney T, et al. Accelerating the delivery of cancer care at home during the covid-19 pandemic. NEJM Catalyst Innovations in Care Delivery. 2020."},{"issue":"1","key":"10.1016\/j.xphs.2026.104159_bib0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12885-022-09461-z","article-title":"Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer","volume":"22","author":"Nipp","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xphs.2026.104159_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1477-7525-11-163","article-title":"Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design","volume":"11","author":"Lal","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.xphs.2026.104159_bib0008","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.medmal.2020.10.019","article-title":"Home intravenous antibiotherapy and the proper use of elastomeric pumps: systematic review of the literature and proposals for improved use","volume":"51","author":"Diamantis","year":"2021","journal-title":"Infect Dis Now"},{"issue":"6","key":"10.1016\/j.xphs.2026.104159_bib0009","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1213\/ane.0b013e318187c9bb","article-title":"Elastomeric pump reliability in postoperative regional anesthesia: a survey of 430 consecutive devices","volume":"107","author":"Remerand","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.xphs.2026.104159_bib0010","author":"Bruijn"},{"issue":"8","key":"10.1016\/j.xphs.2026.104159_bib0011","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.xphs.2018.04.005","article-title":"Postproduction handling and administration of protein pharmaceuticals and potential instability issues","volume":"107","author":"Nejadnik","year":"2018","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104159_bib0012","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.xphs.2023.11.014","article-title":"Use of closed system transfer devices (CSTDs) with protein-based therapeutic drugs-a non-solution for a non-problem?","volume":"113","author":"Fast","year":"2024","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104159_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41598-021-03780-0","article-title":"Frequency and component analysis of contaminants generated in preparation of anticancer agents using closed system drug transfer devices (CSTDs)","volume":"12","author":"Sumikawa","year":"2022","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.xphs.2026.104159_bib0014","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1002\/jps.22676","article-title":"Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution","volume":"100","author":"Nayak","year":"2011","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104159_bib0015","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/jps.21530","article-title":"Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality","volume":"98","author":"Carpenter","year":"2009","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104159_bib0016","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.22097","article-title":"An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics","volume":"99","author":"Singh","year":"2010","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104159_bib0017","first-page":"1218","article-title":"Determining antibody stability: creation of solid-liquid interfacial effects within a high shear environment","volume":"23","author":"Biddlecombe","year":"2007","journal-title":"Biotechnol Prog"},{"issue":"3","key":"10.1016\/j.xphs.2026.104159_bib0018","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/s12248-019-0312-3","article-title":"Interfacial stress in the development of biologics: fundamental understanding, current practice, and future perspective","volume":"21","author":"Li","year":"2019","journal-title":"Aaps J"},{"issue":"6","key":"10.1016\/j.xphs.2026.104159_bib0019","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/jps.23973","article-title":"Protein aggregation and particle formation in prefilled glass syringes","volume":"103","author":"Gerhardt","year":"2014","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104159_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.11.014","article-title":"Protein aggregation and its inhibition in biopharmaceutics","volume":"289","author":"Wang","year":"2005","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2026.104159_bib0021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/138920109788488932","article-title":"Mechanisms of protein aggregation","volume":"10","author":"Philo","year":"2009","journal-title":"Curr Pharm Biotechnol"},{"issue":"8","key":"10.1016\/j.xphs.2026.104159_bib0022","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/jps.23225","article-title":"Particles shed from syringe filters and their effects on agitation-induced protein aggregation","volume":"101","author":"Liu","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104159_bib0023","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijbiomac.2018.06.105","article-title":"Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles","volume":"118","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2026.104159_bib0024","unstructured":"Elastomeric Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030) [Available from: https:\/\/www.mordorintelligence.com\/industry-reports\/elastomeric-infusion-pumps-market."},{"key":"10.1016\/j.xphs.2026.104159_bib0026","unstructured":"Administration USFaD. Herzuma FDA label [Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761091s001s002lbl.pdf."},{"issue":"8","key":"10.1016\/j.xphs.2026.104159_bib0027","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/jps.2600610842","article-title":"Determination of CMC of polysorbate 20 in aqueous solution by surface tension method","volume":"61","author":"Mittal","year":"1972","journal-title":"J Pharmaceut Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104159_bib0028","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/jps.21566","article-title":"Protein aggregation: pathways, induction factors and analysis","volume":"98","author":"Mahler","year":"2009","journal-title":"J Pharm Sci"},{"issue":"20","key":"10.1016\/j.xphs.2026.104159_bib0029","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1080\/10826076.2012.743724","article-title":"Size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates","volume":"35","author":"Hong","year":"2012","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104159_bib0030","first-page":"3161","article-title":"The importance of handling high-value biologicals: physico-chemical instability and immunogenicity of monoclonal antibodies","volume":"15","author":"Lapto\u0161","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.xphs.2026.104159_bib0031","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1023\/B:PHAM.0000029275.41323.a6","article-title":"Structure-immunogenicity relationships of therapeutic proteins","volume":"21","author":"Hermeling","year":"2004","journal-title":"Pharmaceut Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104159_bib0032","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2013.02.039","article-title":"Long-term physico-chemical stability of diluted trastuzumab","volume":"448","author":"Paul","year":"2013","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2026.104159_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.104011","article-title":"Quality (Attributes) over quantity: minimal essential quality attributes for determining antibody stability in postproduction handling stability studies","volume":"114","author":"van den Berg","year":"2025","journal-title":"J Pharmaceut Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104159_bib0034","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/17434440.2019.1632187","article-title":"Flow rate accuracy of ambulatory elastomeric and electronic infusion pumps when exposed to height and back pressures experienced during home infusion therapy","volume":"16","author":"Hobbs","year":"2019","journal-title":"Expert Rev Med Devices"},{"issue":"9","key":"10.1016\/j.xphs.2026.104159_bib0035","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/antibiotics12091351","article-title":"Effectiveness and safety of elastomeric pumps for delivery of antibiotics to adult hospital inpatients\u2014a systematic review","volume":"12","author":"Spencer-Jones","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.xphs.2026.104159_bib0036","unstructured":"Inc. BBM. Easypump\u00ae ST\/LT flow rate influencing factors 2018 [Available from: https:\/\/www.bbraunusa.com\/content\/dam\/catalog\/bbraun\/bbraunProductCatalog\/S\/AEM2015\/en-us\/b\/easypump-st-lt-flowrateinfluencingfactors.pdf."},{"issue":"6","key":"10.1016\/j.xphs.2026.104159_bib0037","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/19420862.2016.1189048","article-title":"A comparison of biophysical characterization techniques in predicting monoclonal antibody stability","volume":"8","author":"Thiagarajan","year":"2016","journal-title":"MAbs"},{"issue":"10","key":"10.1016\/j.xphs.2026.104159_bib0038","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1002\/jps.22597","article-title":"Effects of surfaces and leachables on the stability of biopharmaceuticals","volume":"100","author":"Bee","year":"2011","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:33:01Z","timestamp":1772721181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022354926000080"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104159","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability of therapeutic monoclonal antibodies during infusion with elastomeric pumps intended for home-based therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104159"}}